Telehealth General Psychiatry Prescribing: What Prescribers Can Do in Georgia

If you’re a psychiatrist or PMHNP exploring telehealth, you’ve probably asked yourself: Can I legally prescribe medications—including controlled substances like Adderall or Xanax—through video visits? The short answer in 2026 is yes, in most cases—but the rules vary significantly by state, provider type, and medication schedule.

This guide breaks down exactly what psychiatrists and psychiatric nurse practitioners can prescribe via telehealth, the federal and state regulations you need to know, and how scope-of-practice differences between MDs and NPs affect your prescribing authority. Whether you’re managing ADHD medications, antidepressants, or controlled substances for anxiety, understanding these rules protects your license and ensures you’re maximizing your ability to serve patients remotely.

The Current State of Telehealth Prescribing: What Changed After COVID

Before 2020, federal law (the Ryan Haight Act) required an in-person medical evaluation before prescribing any controlled substance (Schedule II–V drugs like stimulants, benzodiazepines, or buprenorphine). This effectively blocked psychiatrists from initiating ADHD or anxiety treatment via telemedicine for new patients.

The COVID-19 public health emergency changed everything. The DEA issued temporary waivers allowing providers to prescribe controlled substances via telehealth without an initial in-person visit, as long as the encounter met the standard of care through audio-visual communication. These flexibilities have been extended through December 31, 2025 and remain in effect as of early 2026.

What this means today:

• Psychiatrists can start new patients on Schedule II stimulants (Adderall, Ritalin), benzodiazepines (Xanax, Klonopin), or buprenorphine (Suboxone) entirely via video visits, nationwide
• PMHNPs in states with full practice authority can do the same (though state-specific NP scope rules apply—more on that below)
• You must still conduct a thorough clinical evaluation via real-time audio-visual telemedicine (not just phone or messaging)
• State-specific rules may impose additional requirements or carve-outs

Important caveat: The DEA has proposed new permanent rules that could reinstate some in-person requirements or introduce a special telemedicine registration. Providers should monitor DEA announcements in late 2024/early 2025 for final rulemaking, but current waivers remain valid through the end of 2025.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Federal Rules: What You Need to Know About Teleprescribing Controlled Substances

The Ryan Haight Act and Current DEA Waivers

The Ryan Haight Online Pharmacy Consumer Protection Act (2008) requires a ‘valid prescription’ for controlled substances, which normally means the prescriber conducted at least one in-person medical evaluation. However, under the DEA’s temporary telemedicine rules (extended multiple times since March 2020), psychiatrists can prescribe controlled substances via telehealth if:

1. The telemedicine encounter uses two-way interactive audio-visual communication (video required, not just phone)
2. The evaluation meets the same standard of care as an in-person visit (documenting history, mental status exam, treatment plan)
3. The prescriber holds a valid DEA registration and state medical license in the state where the patient is located
4. You comply with any additional state requirements (more below)

This waiver applies to all Schedule II–V medications, meaning psychiatrists can currently prescribe:

• Schedule II stimulants (amphetamine salts, methylphenidate) for ADHD
• Schedule III–IV medications (benzodiazepines like alprazolam or clonazepam; buprenorphine for opioid use disorder)
• Schedule V drugs (low-dose codeine cough syrups, pregabalin—though rarely used in psychiatry)

What Happens After the Waivers Expire?

The DEA’s proposed permanent telemedicine rules (still in draft) include possible pathways like:

• A special telemedicine DEA registration for providers who only practice remotely
• Allowing 30-day initial prescriptions via telehealth before requiring in-person follow-up
• Exceptions if the patient had a recent in-person exam by another provider within the past year

These proposals haven’t been finalized. Most experts expect some form of continued telemedicine flexibility for psychiatric care, given bipartisan support and the access crisis in mental health. But you should prepare for potential changes—such as needing to see telehealth patients in-person at least once annually or coordinating with local providers for initial exams.

Bottom line: As of 2026, full teleprescribing is allowed under the DEA waiver. Stay alert for rule changes and be ready to adapt your practice if new requirements take effect.

State-Specific Rules: How Telehealth Prescribing Varies

While federal waivers opened the door, state laws still govern the specifics of telemedicine practice. Some states explicitly allow controlled substance prescribing via telehealth for psychiatric treatment; others impose restrictions on certain medications or require additional protocols. Here’s how the major states handle it:

California

• Telehealth prescribing allowed: Yes, including controlled substances
• Key rule: California requires a ‘good faith prior examination’ before prescribing, but telehealth exams (video) satisfy this requirement. No in-person mandate.
• Controlled substances: Under the DEA waiver, CA psychiatrists can prescribe Schedule II–V drugs via video. Must check CURES (California’s prescription monitoring program) before prescribing Schedule II–IV medications.
• Parity: California law (AB 744) requires private insurers to reimburse telehealth at parity with in-person for mental health services
• NP scope: PMHNPs with less than 3 years experience need physician collaboration; experienced NPs (post-2023) can practice with expanded authority; by 2026, eligible NPs can achieve full independence (no physician required)

Texas

• Telehealth prescribing allowed: Yes, but with pain management restrictions
• Key rule: Texas law permits teleprescribing if the standard of care is met via real-time audio-visual telemedicine. However, prescribing opioids for chronic pain via telehealth is prohibited—must have in-person exam
• Psychiatric exception: Texas does allow tele-prescribing of controlled substances for mental health treatment (ADHD stimulants, anti-anxiety meds). This is explicitly permitted for psychiatric conditions, just not for long-term pain management
• Prescription monitoring: Must check Texas PMP before prescribing any controlled substance (telemed or in-person)
• NP scope: PMHNPs in Texas cannot practice or prescribe independently—they must have a Prescriptive Authority Agreement with a physician. Texas NPs generally cannot prescribe Schedule II drugs in outpatient settings (except narrow exceptions like terminal illness), so ADHD stimulants are typically prescribed by the collaborating psychiatrist. Texas law caps physician supervision at 7 NPs per physician

Practical takeaway for Texas: Psychiatrists have full authority to manage ADHD and anxiety meds via telehealth. NPs face significant restrictions and must work under physician delegation.

Florida

• Telehealth prescribing allowed: Yes—Florida explicitly permits controlled substance prescribing via telehealth for psychiatric disorders
• Key statute: Florida Statutes §456.47 and §464.012 allow teleprescribing of controlled substances for treatment of mental illness (as well as hospice/inpatient care). This is one of the most provider-friendly state laws for telepsychiatry
• 7-day limit exception: Florida generally caps NP-prescribed Schedule II drugs at 7 days, but ‘psychiatric nurses’ (PMHNPs with 2+ years experience) treating mental health conditions are exempt from that limit—they can prescribe stimulants and psychotropics for more than 7 days
• NP scope: Florida granted ‘autonomous practice’ to some NPs in 2020 (HB 607), but psychiatric NPs were excluded. PMHNPs still require a supervising physician protocol. However, a qualified PMHNP (‘psychiatric nurse’ per statute) can prescribe controlled psychotropics in collaboration with a psychiatrist
• Reimbursement: No mandated parity, but many FL insurers cover tele-mental health equally

Florida is a telehealth-friendly state for psychiatrists, with explicit legal support for controlled substance prescribing via video.

New York

• Telehealth prescribing allowed: Yes, fully aligned with federal DEA waivers as of 2025
• Key rule: In 2025, New York finalized regulations removing state-level barriers to controlled substance prescribing via telehealth. NY now defers to federal law—if the DEA waiver allows it, so does New York
• Requirements: Must use real-time audio-visual telehealth for initial controlled substance prescriptions (phone-only not sufficient for Schedule II–IV). NY requires e-prescribing for all controlled substances (no paper scripts)
• I-STOP law: Psychiatrists must check New York’s Prescription Monitoring Program (PMP) registry before prescribing any Schedule II–IV drug
• NP scope: PMHNPs with ≥3,600 hours (roughly 2 years) of supervised practice can practice independently without a collaborative agreement. New NPs need initial physician collaboration

New York’s recent rule changes make it one of the clearest states for telepsychiatry prescribing—especially for experienced NPs.

Pennsylvania

• Telehealth prescribing allowed: Yes, under federal allowances (no unique state ban)
• Key rule: PA has no special state restrictions on teleprescribing controlled substances for mental health—providers follow federal DEA rules
• Collaboration: PA NPs must have a collaborative agreement with a physician to prescribe (no independent practice). The agreement must specify prescriptive authority, and Schedule II prescriptions by NPs are limited to 30-day supply with physician notification within 24 hours
• Reimbursement: Pennsylvania Medicaid and most commercial insurers cover telepsychiatry, but the state lacks a comprehensive telehealth parity statute (legislation pending)

PA is straightforward for psychiatrists; NPs face ongoing supervision requirements that haven’t changed despite neighboring states granting independence.

Illinois

• Telehealth prescribing allowed: Yes, with strong legislative support
• Key rule: Illinois permits teleprescribing under standard of care requirements. No special in-person mandates for mental health controlled substances
• Parity law: Illinois law (SB 667, 2021) requires equal reimbursement for telehealth services through at least 2027, especially for behavioral health
• NP scope: PMHNPs must complete 4,000 hours of physician-supervised practice + 250 hours of continuing education, after which they can apply for Full Practice Authority and prescribe independently (including controlled substances)
• Unique detail: Illinois allows specially trained clinical psychologists to prescribe a limited formulary of psych meds under psychiatrist supervision (rare, but shows state’s progressive stance on access)

Illinois is a telehealth leader with clear NP pathways to independence and strong reimbursement protections.

Psychiatrist vs PMHNP Prescribing Authority: What’s the Difference?

While psychiatrists have universal independent prescribing authority in all states, PMHNPs face a patchwork of state-specific rules. Understanding these differences is crucial if you’re building a multi-state telehealth practice or deciding which providers to hire.

Psychiatrists (MD/DO)

• Scope: Full authority to evaluate, diagnose, and prescribe any psychiatric medication (including all controlled substances) in every state
• Independence: No supervision or collaborative agreements required
• Telehealth: Can prescribe via telemedicine in any state where they hold a medical license, subject only to federal DEA rules and state-specific telehealth laws
• Reimbursement: Paid at 100% of fee schedule by Medicare and most commercial payers

Psychiatric Mental Health NPs (PMHNPs)

• Scope: Depends entirely on state law—ranges from fully independent (34 states as of 2025) to requiring continuous physician supervision (16 states)
• Three categories of state NP authority:

1. Full Practice Authority (FPA): NPs can diagnose, treat, and prescribe independently (Washington, Oregon, Colorado, Arizona, New Mexico, most New England states, etc.)
2. Reduced Practice: NPs need a collaborative agreement with a physician for certain functions (usually prescribing). Often includes a transition to independence after experience (New York after 3,600 hours; Illinois after 4,000 hours; California after 3 years)
3. Restricted Practice: NPs must work under physician supervision/delegation indefinitely (Texas, Florida for psych NPs, Pennsylvania, Tennessee, others)

• Controlled substances: In FPA states, PMHNPs can prescribe Schedule II–V just like psychiatrists. In restricted states, they often cannot prescribe Schedule II (or require physician co-signature), and some states require the collaborating physician to be a psychiatrist for psych prescribing (Florida requires this for ‘psychiatric nurses’)
• Reimbursement: Medicare pays NPs at 85% of physician rates when billing under their own NPI; some states have passed equal pay laws, but this varies

Key state examples:

• California: New NPs need supervision; experienced NPs (3+ years) gain independence by 2026
• Texas: All NPs need physician delegation; cannot prescribe Schedule II stimulants independently
• Florida: Psych NPs excluded from autonomous practice law—must have psychiatrist collaboration for controlled psych meds
• New York: After 3,600 hours, NPs practice independently with no restrictions
• Pennsylvania: All NPs need collaborative agreements (no independence pathway yet)
• Illinois: After 4,000 hours + CE, NPs can practice fully independently

Collaborative Practice Agreements: What They Require

In states without FPA, PMHNPs must have a written collaborative practice agreement (CPA) with a physician. These agreements typically specify:

• Scope of prescribing: Which drug schedules the NP can prescribe (often excluding Schedule II in restricted states)
• Chart review: Physician must review a percentage of NP charts monthly or quarterly (e.g., 10% in South Carolina, Pennsylvania)
• Availability: Physician must be available for consultation (often by phone/video for telehealth practices)
• Meetings: Some states require regular face-to-face meetings (Texas requires monthly for first 3 years, then quarterly)
• Filing: Many states require filing the CPA with the nursing board

Pain point: Finding a collaborating psychiatrist can be challenging and expensive (many charge $1,000–$5,000+ annually for collaboration). This is especially difficult for PMHNPs in rural or underserved areas.

Billing and Reimbursement for Telehealth Medication Management

One of the biggest questions providers have: Will I get paid the same for telehealth visits?

Medicare Reimbursement Rates (2026)

Medicare has made most telehealth mental health services permanent with payment parity. For 2026, typical rates for psychiatrists include:

NP rates: PMHNPs billing under their own NPI receive 85% of these amounts from Medicare (e.g., $81 for 99213, $116 for 99214).

Add-on psychotherapy codes: If you’re doing combined therapy + med management, you can bill an E/M code plus a psychotherapy add-on (e.g., 99213 + 90833 for 16–37 minutes of therapy adds ~$80).

Private Insurance

Commercial payers often pay more than Medicare—commonly $150–$200 for a 25-minute med check in urban markets. About 43 states have telehealth parity laws requiring equal coverage for mental health services, and many mandate equal payment.

States with strong parity:

• California (AB 744): Payment parity required
• Illinois (SB 667): Equal reimbursement mandated through 2027
• New York: Parity coverage with most insurers voluntarily paying equal rates

Texas has coverage requirements but not payment parity—insurers can negotiate different rates, though most pay equally for tele-mental health given demand.

Medicaid

State Medicaid programs vary widely, but most expanded telehealth coverage during COVID and made it permanent. Rates are typically lower than Medicare:

• Florida Medicaid: ~$60–$80 for a med check
• California Medi-Cal: Roughly 75% of Medicare rates (with recent increases for behavioral health)
• New York Medicaid: Strong parity—pays same as in-person

Audio-Only Telehealth

Medicare and some state Medicaid programs now reimburse audio-only (phone) mental health visits at the same rate as video—helpful for patients without broadband access. This is currently extended through 2024–2025 for Medicare mental health services.

No-Show Rates and Revenue Reality

One underappreciated benefit of telehealth: lower no-show rates. Many providers report 10–20% no-shows for in-office appointments drop to 5–10% for video visits (patients can join from home, work, or their car). This directly improves your effective revenue per hour.

The Economics of Building a Telehealth Psychiatry Practice

Let’s talk about what actually matters to your bottom line: patient acquisition cost and revenue potential.

The DIY Marketing Trap

Many providers think they’ll save money by marketing their own practice through SEO, Google Ads, or directory listings. The reality:

• SEO takes 6–12 months of consistent investment (content, technical optimization, backlinks) before generating meaningful patient flow. You’re looking at $2,000–$5,000+/month for a professional agency or countless hours of your own time—all before seeing a single patient.

• Google Ads for mental health keywords run $15–$40+ per click in competitive markets. A realistic cost per booked patient (not just a click) is $200–$400+ when you factor in:

• Testing and optimizing campaigns (3–6 months)

• Clicks from unqualified leads or people just browsing

• No-show rates from cold leads (30–40% common)

• Staff time to handle inquiries and schedule

• Directory listings (Psychology Today, Zocdoc, TherapyDen) charge monthly subscription fees ($30–$100+/month) plus per-booking fees (Zocdoc charges $35–$100+ per booking). You’re competing with hundreds of other providers on the same page, so conversion rates are low. Total monthly cost for multiple directories: easily $200–$500 before seeing ROI.

Reality check: When you add up agency fees, ad spend, staff time, wasted budget on clicks that don’t convert, and months of investment before results—your true cost per acquired patient through DIY marketing is typically $300–$500+. And that’s per new patient, not per visit.

The Platform Economics Advantage

This is where platforms like Klarity Health change the equation entirely.

Instead of gambling $3,000–$5,000/month on marketing with uncertain results, Klarity uses a pay-per-appointment model:

• Zero upfront marketing spend: No monthly retainers, no ad budget, no SEO investment required
• Pre-qualified patients: Every patient lead is already matched to your specialty, availability, and insurance acceptance
• No wasted spend: You only pay when a qualified patient actually books with you (similar to Zocdoc’s model but with better matching)
• Built-in infrastructure: Telehealth platform, scheduling, billing support included—no separate software costs
• Both insurance and cash-pay: Patient mix includes commercially insured and self-pay patients
• You control your schedule: Only accept the patients you want; scale up or down without penalty

The math: If you’re paying a standard listing fee per new patient (let’s say comparable to what you’d spend acquiring that patient yourself), but you’re getting:

• Guaranteed qualified leads (no clicks from tire-kickers)
• Zero risk on wasted marketing spend
• Immediate patient flow (no 6-month SEO wait)
• No staff time handling unqualified inquiries

…then your effective cost per patient is actually lower than DIY marketing, with zero financial risk.

Example: A psychiatrist joining Klarity might see 15–20 new patients per month within 60 days, with each patient converting to 8–12 follow-ups annually. Compare that to spending $5,000/month on marketing for 3–6 months before seeing even 10 new patients/month—and you’re still not sure those leads will show up or convert.

Bottom line: For most providers—especially those starting out, expanding to new states, or scaling from solo practice—a platform that handles patient acquisition removes the biggest financial risk and time sink in building a telehealth practice.

Revenue Potential

What can you actually earn? Here’s a realistic breakdown:

Full-time telehealth psychiatrist (30–35 patient appointments/week):

• 20 hours clinical time (30–35 patients at 30–40 min average)
• Mix of initial evals ($150–$250) and follow-ups ($100–$150)
• Gross revenue: $12,000–$18,000/month
• After platform fees or overhead (30–40%): $7,200–$11,000/month take-home

Part-time PMHNP (15–20 patients/week, 10 clinical hours):

• Similar patient mix at 85% physician rates (or 100% if cash/out-of-network)
• Gross revenue: $5,000–$8,000/month
• After overhead: $3,000–$5,000/month take-home

Key advantage: These numbers assume you’re working with a platform handling acquisition. If you’re doing it yourself, subtract 20–30% of your time for marketing, admin, and lead management—dropping your effective hourly rate significantly.

FAQ: Telehealth Prescribing for Psychiatrists and PMHNPs

Can psychiatrists prescribe controlled substances like Adderall or Xanax via telehealth?

Yes. Under current DEA waivers (extended through December 31, 2025), psychiatrists can prescribe Schedule II–V controlled substances via telehealth without an initial in-person visit, as long as the evaluation is conducted via real-time audio-visual communication and meets the standard of care. This includes stimulants for ADHD, benzodiazepines for anxiety, and buprenorphine for opioid use disorder.

Do I need to see patients in-person before prescribing controlled substances?

Not currently, thanks to the DEA’s temporary telemedicine flexibilities. However, this could change if the DEA finalizes new permanent rules. Some proposals include allowing a 30-day initial prescription via telehealth before requiring in-person follow-up, or requiring an annual in-person visit. Monitor DEA announcements for updates.

Can PMHNPs prescribe the same medications as psychiatrists via telehealth?

It depends on the state. In states with Full Practice Authority (like Washington, Colorado, Arizona, New York after 3,600 hours, Illinois after 4,000 hours), PMHNPs have the same prescribing authority as psychiatrists for telehealth. In restricted states (Texas, Florida, Pennsylvania), PMHNPs need physician collaboration and often cannot prescribe Schedule II stimulants independently.

Do I need a separate license for each state I practice telehealth in?

Yes. You must be licensed in the state where the patient is located at the time of the visit, not just where you’re physically sitting. The Interstate Medical Licensure Compact (IMLC) helps psychiatrists get licenses faster in member states (Texas, Pennsylvania, Illinois are members; California, New York, Florida are not). Some states offer special telehealth registrations, but these often restrict prescribing.

What are the reimbursement differences between in-person and telehealth visits?

For psychiatry, there is payment parity in most states. Medicare pays the same for telehealth mental health visits as in-person visits. Most state Medicaid programs and private insurers with parity laws (California, Illinois, New York, etc.) also pay equally. Some states (like Texas) don’t mandate parity, but most insurers voluntarily pay the same given high demand for tele-mental health.

How do I check if a patient is getting controlled substances from other providers?

Every state has a Prescription Drug Monitoring Program (PDMP) that you must check before prescribing controlled substances. Examples: CURES in California, I-STOP in New York, Texas PMP. Most states require checking before any Schedule II–IV prescription (some require it for every prescription, others just at initiation and periodically). This applies equally to telehealth and in-person prescribing.

Can I do audio-only (phone) prescribing for controlled substances?

No. The DEA waiver requires two-way interactive audio-visual communication (video) for prescribing controlled substances via telehealth. Audio-only does not qualify. However, Medicare and some states allow audio-only visits for non-controlled medication management (like SSRIs, antipsychotics) and will reimburse those visits.

What documentation do I need for telehealth controlled substance prescribing?

Document the same elements as an in-person visit: chief complaint, history, mental status exam, diagnosis, treatment plan, risks/benefits discussed. Additionally, note:

• That the visit was conducted via telehealth (technology used)
• Patient’s location (city/state)
• That you verified patient identity
• That you checked the state PDMP (include date/findings)
• Patient consent for telehealth treatment

Do I need malpractice insurance that covers telehealth?

Yes. Most malpractice policies now include telehealth, but verify your policy covers the states where you’re licensed and practicing. Some insurers charge a small premium add-on for multi-state telehealth coverage.

What happens if the DEA rules change in 2025?

If new permanent rules require in-person visits, you’ll need to either:

• Coordinate with local providers for initial in-person exams before starting controlled substances via telehealth
• Limit your telehealth practice to non-controlled medications (SSRIs, mood stabilizers, antipsychotics)
• See patients in-office periodically
• Apply for any new special telemedicine DEA registration if created

Most experts expect some flexibility to remain for psychiatric care given access needs, but prepare for possible adjustments.

Next Steps: Building Your Telehealth Prescribing Practice

Understanding the regulations is step one. Step two is building a practice that actually generates income without drowning you in marketing overhead.

If you’re a psychiatrist or PMHNP looking to expand into telehealth—or scale an existing practice—here’s what makes sense:

✅ Get licensed in the states with the highest demand and best scope-of-practice fit (California, New York, Illinois for experienced NPs; any state for psychiatrists)

✅ Register with the DEA in each state where you’ll prescribe controlled substances

✅ Enroll in state PMPs (prescription monitoring programs) for every state you practice in

✅ Verify your malpractice coverage includes multi-state telehealth

✅ Choose between two paths:

• DIY: Spend 6–12 months and $3,000–$5,000/month building your own marketing (SEO, ads, directories, website) with no guaranteed patient flow
• Platform: Join a provider network like Klarity Health where patient acquisition is handled for you, and you pay only when patients book—zero upfront risk, immediate patient flow, built-in infrastructure

Why Klarity Makes Sense for Most Providers

Klarity’s model solves the biggest pain point in telehealth psychiatry: expensive, unreliable patient acquisition.

Instead of competing for patients on Psychology Today or burning ad budget on Google hoping someone books, Klarity matches you with pre-qualified patients who:

• Are already seeking psychiatric medication management
• Match your availability and specialties (ADHD, depression, anxiety, etc.)
• Are insurance-verified or ready to pay (both commercial and cash patients)
• Have been vetted for appropriateness (reducing no-shows and unqualified leads)

You control your schedule, accept only the patients you want, and scale up or down based on your capacity. No monthly fees, no wasted marketing spend, no risk.

For psychiatrists: Full prescribing authority in all states means you can serve high-value patients (ADHD, complex med management) with minimal restrictions.

For PMHNPs in FPA states (or experienced NPs in NY/IL/CA): You can practice independently and build your patient panel without the cost and complexity of finding a collaborating physician.

For PMHNPs in restricted states (TX, FL, PA): Klarity’s platform often provides collaborative oversight or connects you with supervising psychiatrists, removing the biggest barrier to starting your telehealth practice.

Ready to start? Explore Klarity Health’s provider network to see how you can skip the marketing gamble and start seeing patients within weeks—not months.

Sources and References

1. California Board of Registered Nursing – AB 890 FAQs (rn.ca.gov) | Official state regulatory board | Updated Nov 2023 | Primary source on CA NP scope implementation

2. Texas Board of Nursing – APRN Practice FAQ (bon.texas.gov) | Official state board FAQ | Revised 2021 | Primary source for TX NP collaboration mandate

3. Florida Statutes Chapter 464 & 456 (flsenate.gov) | Official state statutes | 2024 compilation | Primary legal text on FL NP scope and telehealth controlled substances

4. Center for Connected Health Policy – Texas Telehealth Laws (cchpca.org) | Non-profit policy database | Updated Jan 2026 | Comprehensive summary of TX telehealth regulations

5. National Law Review – Telehealth Prescribing Update (natlawreview.com) | Legal analysis | Aug 2025 | Summary of federal DEA waivers and state law changes

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship